What are the treatment options for chronic migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Chronic Migraine

For chronic migraine, the most effective evidence-based treatment options include topiramate, onabotulinumtoxinA (Botox), and CGRP monoclonal antibodies, with topiramate recommended as first-line therapy due to its proven efficacy and lower cost. 1

Definition and Diagnosis

Chronic migraine is defined as:

  • Headaches occurring on ≥15 days per month for at least 3 months
  • With migraine features present on ≥8 days per month 1
  • Not attributable to another cause

A headache diary is essential for accurate diagnosis, as patients may underreport milder headache days 1.

Treatment Algorithm

First-Line Preventive Therapy:

  • Topiramate:
    • Starting dose: 25mg daily
    • Gradually titrate to target dose of 100mg daily (can range from 50-200mg based on patient response)
    • Proven effective in randomized controlled trials specifically for chronic migraine 1, 2
    • Common side effects: paresthesia (53%), nausea (9%), dizziness (6%), fatigue (6%), cognitive issues 2

Second-Line Preventive Therapies:

  • OnabotulinumtoxinA (Botox):

    • Only FDA-approved therapy specifically for chronic migraine prophylaxis 1, 3
    • Administered by headache specialists using standardized injection protocol
    • Warning: Monitor for swallowing or breathing problems, which can occur hours to weeks after injection 3
    • Typically reserved for patients who have failed at least 2-3 other preventive medications due to regulatory restrictions 1
  • CGRP Monoclonal Antibodies (erenumab, fremanezumab, galcanezumab):

    • Proven beneficial for patients who failed at least two other preventive medications 1
    • Typically reserved as third-line due to cost and access issues

Acute Treatment for Breakthrough Headaches:

  1. First-line: NSAIDs (acetylsalicylic acid, ibuprofen, diclofenac potassium) 1

    • Take early in the attack while pain is still mild
  2. Second-line: Triptans (e.g., sumatriptan) 1

    • Contraindicated in patients with cardiovascular disease, uncontrolled hypertension, or history of stroke 4
    • Risk of medication overuse headache with frequent use
    • Warning: Can cause chest/throat/neck tightness, cerebrovascular events in rare cases 4

Managing Medication Overuse Headache (MOH)

MOH is common in chronic migraine patients (up to 78% in some studies) 2:

  • Defined as headache occurring ≥15 days/month due to regular overuse of acute headache medication 1
  • Management requires withdrawal of overused medication
  • Abrupt withdrawal is preferred (except for opioids) 1
  • Preventive therapy can be started concurrently with withdrawal or upon re-emergence of headache 1

Addressing Comorbidities

Identify and manage common comorbidities that can affect treatment outcomes 1, 5:

  • Depression/anxiety: Consider amitriptyline as preventive therapy
  • Sleep disorders: Improve sleep hygiene, consider amitriptyline
  • Obesity: Topiramate may be preferred (associated with weight loss)
  • Stress: Incorporate stress management techniques

Non-Pharmacological Approaches

Incorporate these strategies alongside medication 1, 5:

  • Stress management techniques
  • Regular sleep schedule
  • Regular meals and hydration
  • Moderate exercise (at least 40 minutes, three times weekly)
  • Identification and avoidance of triggers when possible

Treatment Monitoring and Follow-up

  • Use headache calendars to track frequency, severity, and medication use
  • Evaluate effectiveness after 2-3 months of consistent treatment
  • Set realistic expectations: goal is significant reduction in headache frequency/severity, not complete elimination
  • Long-term management typically returns to primary care after specialist consultation 1

Important Caveats

  • Avoid opioids for migraine management due to high risk of medication overuse and dependence
  • Limit acute medications to <2 days per week to prevent medication overuse headache 1, 4
  • Recognize that chronic migraine treatment is typically long-term, not short-term
  • Consider referral to headache specialist for patients with refractory symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chronic Tension-Type Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.